Table 7. Optimized proliposomes in vitro aerosol assessment .
| P11 | P18 | |
| MMAD | 5.25 ± 0.02 | 6.21 ± 0.36 |
| GSD | 5.42 ± 0.80 | 2.36 ± 0.25 |
| FPF% | 0.71 ± 0.06 | 9.17 ± 0.18 |
| Emitted dose (mg) | 0.95 ± 0.21 | 1.63 ± 0.25 |
| Powder recovery% | 75.91 ± 3.52 | 90.15 ± 3.01 |
| P11 | P18 | |
| MMAD | 5.25 ± 0.02 | 6.21 ± 0.36 |
| GSD | 5.42 ± 0.80 | 2.36 ± 0.25 |
| FPF% | 0.71 ± 0.06 | 9.17 ± 0.18 |
| Emitted dose (mg) | 0.95 ± 0.21 | 1.63 ± 0.25 |
| Powder recovery% | 75.91 ± 3.52 | 90.15 ± 3.01 |